![]() |
|
Since bsAbs are highly engineered and often have complex structures, they can be prone to aggregation and problematic post-translational modifications, leading to low-titer, immunogenicity and immunotoxicity problems. This white paper explains how early developability assessment and analysis at early-stage development can help you select the best lead candidates and the optimum cell line.
|